Quality Systems for CMOs & CDMOs — A Buyer's Guide
A Contract Manufacturing Organization (CMO) or Contract Development & Manufacturing Organization (CDMO) sells one product: trustworthy execution. Sponsors don't only audit your facility — they audit your quality system. In 2026 the bar has risen: pharma sponsors expect near-real-time visibility into their batch, ICH Q10 alignment, ICH Q9 risk-based change control, GxP-compliant data segregation across multiple clients on shared equipment, and an inspection-ready trail for every product they own at your site. This guide explains what sponsors are actually asking on the quality questionnaire, where most CMO/CDMO quality systems fall short, and how to pick software that scales beyond a single anchor client. Written for ops, quality, and BD leaders at small-molecule, biologics, sterile, solid-dose, and specialty CMO/CDMOs.
What sponsors actually check on a CMO audit
Multi-client data segregation on shared equipment
Change control across sponsors — ICH Q9 and Q10 in practice
Tech-transfer onboarding — the moment a sponsor commits
Audit-ready in two hours, not two weeks
Buying software that scales beyond one anchor client
Standards covered in this guide
Each standard, retailer code or assurance scheme referenced above has its own deep-dive page with scope, audit detail and common pitfalls.
The international model for a Pharmaceutical Quality System covering the entire product lifecycle from development to discontinuation.
International guideline that mandates risk-based decision-making across the pharma product lifecycle. Underpins everything from supplier qualification to PPQ batch count.
Where this lives in V5 Ultimate
The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.
Real-time per-sponsor visibility with row-level segregation.
Multi-tenant execution on shared equipment without copy-paste.
Per-sponsor batch records with redacted CMO-internal data.
Per-sponsor change branching per quality agreement.
Sponsor-scoped CAPA visibility and routing.
Sponsor-supplied raw materials with per-lot CoA visibility.
Frequently asked
We have a strong anchor client. Do we really need multi-tenant features?
How is a CDMO quality system different from a regular pharma QMS?
What is a sponsor portal and do sponsors actually use them?
What's the typical time-to-live for a new sponsor?
See it on your shop floor.
Free trial, no credit card, onboard in days, not months.
- 10 CFR 35 medical use readiness — NRC licensing for radiopharmaceuticals
- 21 CFR 111 Readiness: Dietary Supplement cGMP Subparts E & F
- 21 CFR 211 Drug cGMP Readiness Guide
- 21 CFR 212 PET drug cGMP readiness — FDA inspection playbook
- 21 CFR 589 BSE / Ruminant Feed Ban Readiness Guide
- 21 CFR Part 11 Readiness Guide for Regulated Manufacturers
